← Leaderboards
Nicole J. Shirkey-Son
Luminary Therapeutics, Inc.
$1,017,866
Attributed
$1,017,866
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $399.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,017,866 · 3
By mechanism
R41$618,208 · 2
R43$399,658 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Mouse Model”
- James Dale Berry · Brigham And Women'S Hospital$25,017,559
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$13,186,126
- Nuno Macarico Da Costa · Allen Institute$11,726,937
- Forrest Christie Collman · Allen Institute$11,726,937
- Jacqueline K White · Jackson Laboratory$11,670,339
- Thomas Dick · Rbhs-New Jersey Medical School$11,611,284
Research focus
Mouse ModelGeneticTissuesEngineeringCellsGenerationsImmuneNovel TherapeuticsT-LymphocyteEngineered T CellsIn VivoGenome EngineeringGraft Vs Host DiseaseGenome-WideGenesGenetic DiseasesHematopoietic Stem CellsFibroblastsDna TransposonsGene MutationEvaluationFda ApprovedArchitectureCell Transplantation
Grant awards (3)
Engineered Memory T cells as a Platform to Treat Enzymopathies$304,838
R41 · FY2025 · AI · contact PI
Engineered gamma delta T cells for systemic correction of dystrophic epidermolysis bullosa$313,370
R41 · FY2024 · AR · contact PI
Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy$399,658
R43 · FY2021 · CA · contact PI